…short-term vaccine-mediated innate immune protection against viral infection or disease does not automatically imply a positive effect of the vaccine on viral infection or morbidity rates in the longer term. Interpretations from scientists who only conduct short-term surveillance studies in vaccinees, the majority of whom are adults or elderly, lead to erroneous, although peer-reviewed conclusions such as: ‘Although vaccines are less effective against asymptomatic disease (*) or against transmission than against severe disease, even in populations with fairly high vaccination rates the unvaccinated are still the major drivers of transmission and are themselves at the highest risk of serious disease’ (6). This clearly illustrates their lack of understanding of the contribution of innate immunity in providing short-term protection after vaccination, and in the more durable protection of young and healthy unvaccinated age groups.
Based on all of the above, it is reasonable to expect booster injections to only enable the virus to more rapidly evolve resistance to the vaccines. This evolution would be dramatically expedited by vaccinating and boosting more and more younger age groups.